Neogen Chemicals Ltd
Fundamental Score
Neogen Chemicals Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of NEOGEN across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (17.09%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Consistent Growth Track Record (20.49% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Balanced Promoter Holding (51.23%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Strong Institutional Confidence (FII+DII: 30.37%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (5.59%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.82%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Premium Valuation Risk (P/E: 90.84x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-69.25%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Elevated Debt Levels (D/E: 1.41)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability and cash flow generation.
Weak Interest Coverage (1.90x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-703.28 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for Neogen Chemicals Ltd
About NEOGEN
Business Overview
Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, specialty polymers, vapor absorption chillers, emerging battery material applications, and other industries. The company also exports its products to 33 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
Company Details
Key Leadership
Corporate Events
NEOGEN Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Neogen Chemicals Ltd (NEOGEN)?
As of 06 Feb 2026, 10:10 am IST, Neogen Chemicals Ltd (NEOGEN) is currently trading at ₹1353.50. The stock has a market capitalization of ₹2.98K (Cr).
Is NEOGEN share price Overvalued or Undervalued?
NEOGEN is currently trading at a P/E ratio of 90.84x, compared to the industry average of 29.20x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Neogen Chemicals Ltd share price?
Key factors influencing NEOGEN's price include its quarterly earnings growth (Sales Growth: 7.91%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Neogen Chemicals Ltd a good stock for long-term investment?
Neogen Chemicals Ltd shows a 5-year Profit Growth of 8.61% and an ROE of 5.59%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.41 before investing.
How does Neogen Chemicals Ltd compare with its industry peers?
Neogen Chemicals Ltd competes with major peers in the Specialty Chemicals. Investors should compare NEOGEN's P/E of 90.84x and ROE of 5.59% against the industry averages to determine its competitive standing.
What is the P/E ratio of NEOGEN and what does it mean?
NEOGEN has a P/E ratio of 90.84x compared to the industry average of 29.20x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹91 for every ₹1 of annual earnings.
How is NEOGEN performing according to Bull Run's analysis?
NEOGEN has a Bull Run fundamental score of 27.3/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does NEOGEN belong to?
NEOGEN operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Neogen Chemicals Ltd.
What is Return on Equity (ROE) and why is it important for NEOGEN?
NEOGEN has an ROE of 5.59%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Neogen Chemicals Ltd generates profits from shareholders' equity.
How is NEOGEN's debt-to-equity ratio and what does it indicate?
NEOGEN has a debt-to-equity ratio of 1.41, which indicates high leverage that increases financial risk. A ratio below 1.0 generally indicates conservative financing.
What is NEOGEN's dividend yield and is it a good dividend stock?
NEOGEN offers a dividend yield of 0.09%, which means you receive ₹0.09 annual dividend for every ₹100 invested.
How has NEOGEN grown over the past 5 years?
NEOGEN has achieved 5-year growth rates of: Sales Growth 20.49%, Profit Growth 8.61%, and EPS Growth 5.98%.
What is the promoter holding in NEOGEN and why does it matter?
Promoters hold 51.23% of NEOGEN shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is NEOGEN's market capitalization category?
NEOGEN has a market capitalization of ₹2984 crores, placing it in the Small-cap category.
How volatile is NEOGEN stock?
NEOGEN has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for NEOGEN?
NEOGEN has a 52-week high of ₹N/A and low of ₹N/A.
What is NEOGEN's operating profit margin trend?
NEOGEN has a 5-year average Operating Profit Margin (OPM) of 17.09%, indicating the company's operational efficiency.
How is NEOGEN's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 7.91% and YoY Profit Growth of -69.25%.
What is the institutional holding pattern in NEOGEN?
NEOGEN has FII holding of 5.15% and DII holding of 25.22%. Significant institutional holding often suggests professional confidence in the stock.